A standardized protocol to reduce cerebrospinal fluid shunt infection: The Hydrocephalus Clinical Research Network Quality Improvement Initiative. Clinical article

Journal of Neurosurgery: Pediatrics

Volumn 8, Issue 1, 2011, Pages 22-29

  Kestle, John R W ^a   Riva Cambrin, Jay ^a   Wellons III, John C ^b   Kulkarni, Abhaya V ^c   Whitehead, William E ^d   Walker, Marion L ^a   Oakes, W Jerry ^b   Drake, James M ^c   Luerssen, Thomas G ^d   Simon, Tamara D ^e   Holubkov, Richard ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Hydrocephalus; Infection; Quality improvement; Shunt; Standardized protocol

Indexed keywords

CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; VANCOMYCIN;

ARTICLE; BLOOD CULTURE; CATHETER; CEREBROSPINAL FLUID SHUNTING; CHILD; HAND WASHING; HEALTH CARE QUALITY; HUMAN; HYDROCEPHALUS; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; METHODOLOGY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOCYST; REOPERATION; SCHOOL CHILD; SHUNT INFECTION; STANDARDIZATION;

ANTIBIOTIC PROPHYLAXIS; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DISINFECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; QUALITY IMPROVEMENT; REOPERATION; SURGICAL WOUND INFECTION;

EID: 79960249659     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2011.4.PEDS10551     Document Type: Article

References (16)

1. Arthur AS, Whitehead WE, Kestle JRW: Duration of antibiotic therapy for the treatment of shunt infection: a surgeon and patient survey. Pediatr Neurosurg 36:256-259, 2002 (Pubitemid 34621739)
2. Cochrane D, Kestle J, Steinbok P, Evans D, Heron N: Model for the cost analysis of shunted hydrocephalic children. Pediatr Neurosurg 23:14-19, 1995
3. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al: Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362:18-26, 2010
4. Drake JM: Editorial. Does double gloving prevent cerebrospinal fluid shunt infection? J Neurosurg 104 (1 Suppl):3-4, 2006
5. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic- impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831-839, 2003 (Pubitemid 37314917)
6. Haynes AB, Weiser TG, Berry WR, Lipsitz SR, Breizat AH, Dellinger EP, et al: A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med 360:491-499, 2009
7. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 33:230-236, 2000 (Pubitemid 32046018)
8. Kestle JR, Drake JM, Cochrane DD, Milner R, Walker ML, Abbott R III, et al: Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial. J Neurosurg 98:284-290, 2003 (Pubitemid 36151021)
9. Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, et al: Management of shunt infections: a multicenter pilot study. J Neurosurg 105 (3 Suppl):177-181, 2006 (Pubitemid 44968407)
10. Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM: Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 35:66-71, 2001 (Pubitemid 32830623)
11. Miller MR, Griswold M, Harris JM II, Yenokyan G, Huskins WC, Moss M, et al: Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 125:206-213, 2010
12. Ragel BT, Browd SR, Schmidt RH: Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg 105:242-247, 2006
13. Rozzelle CJ, Leonardo J, Li V: Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2:111-117, 2008
14. Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, LaFleur B, et al: Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article. J Neurosurg Pediatr 4:156-165, 2009
15. US Food and Drug Administration: Medical Device Recalls: Medtronic Neurologic Technologies, Innervision Snap Shunt Ventricular Catheter, BioGlide and Snap Shunt Ventricular Catheter, BioGlide. (http://www.fda.gov/ MedicalDevices/Safety/RecallsCorrectionsRemovals/ListofRecalls/ucm126620.htm) [Accessed April 28, 2011]
16. Whitehead WE, Kestle JR: The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 35:205-210, 2001